Internal Medicine · Tamarac, FL
NPI
1033281191
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7875 W Commercial Blvd
Tamarac, FL, 33351
Phone (954) 726-0099
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
2,380 services
Medicare patients, 2024
241
Average age 75
Drug cost, 2024
$1.1M
14,748 prescriptions
Company payments, 2025
$2,207
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason M Haffizulla was code 99213 (office e&m - established), 307 times for 142 patients. In total Jason M Haffizulla billed 2,380 services in 72 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 307 | 142 | $65.73 | $20K |
| 36415 Venipuncture Blood Collection | Office | 227 | 128 | $4.90 | $1,112 |
| 99442 Telephone Services | Office | 148 | 96 | $58.68 | $8,685 |
| 99214 Office E&M - Established | Office | 111 | 89 | $88.99 | $9,878 |
| 71046 X-ray - Chest | Office | 103 | 79 | $22.76 | $2,344 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 74 | 74 | $18.66 | $1,381 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 72 | 72 | $18.65 | $1,343 |
| 99212 Office E&M - Established | Office | 55 | 44 | $39.49 | $2,172 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 47 | 47 | $129.88 | $6,104 |
| 93000 Electrocardiogram | Office | 38 | 36 | $11.18 | $425 |
| 70220 Standard X-ray | Office | 33 | 27 | $29.79 | $983 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 32 | 32 | $17.69 | $566 |
| 81002 Clinical Chemistry | Office | 25 | 20 | $3.41 | $85.25 |
| G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 19 | 19 | $7.25 | $138 |
| 85610 Clinical Chemistry | Office | 18 | 13 | $4.20 | $75.6 |
By year: 2022 $97K for 2,243 services; 2023 $77K for 1,749 services; 2024 $74K for 2,380 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 227 | 128 | $4.90 | $1,112 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 32 | 32 | $17.69 | $566 |
| 81002 Clinical Chemistry | 25 | 20 | $3.41 | $85.25 |
| 85610 Clinical Chemistry | 18 | 13 | $4.20 | $75.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason M Haffizulla prescribed most often to Medicare patients was Rosuvastatin Calcium, with 693 prescriptions and refills. In total Jason M Haffizulla wrote 14,748 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 693 | 2,058 | 243 | $5,849 |
| Amlodipine Besylate Generic | 690 | 2,031 | 243 | $2,434 |
| Atorvastatin Calcium Generic | 564 | 1,640 | 200 | $3,600 |
| Losartan Potassium Generic | 441 | 1,275 | 155 | $2,570 |
| Levothyroxine Sodium Generic | 409 | 1,201 | 140 | $2,858 |
| Metformin Hcl Generic | 407 | 1,183 | 145 | $1,605 |
| Pantoprazole Sodium Generic | 379 | 1,089 | 152 | $3,045 |
| Ibuprofen Generic | 307 | 361 | 136 | $1,075 |
| Hydrochlorothiazide Generic | 307 | 896 | 104 | $1,022 |
| Metoprolol Succinate Generic | 269 | 794 | 89 | $2,115 |
| Clarithromycin Generic | 259 | 259 | 209 | $3,950 |
| Gabapentin Generic | 223 | 540 | 92 | $3,661 |
| Simvastatin Generic | 219 | 660 | 73 | $927 |
| Escitalopram Oxalate Generic | 218 | 640 | 83 | $2,206 |
| Lisinopril Generic | 218 | 651 | 76 | $906 |
Brand drugs: 1,479 claims; generic drugs: 13,138 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason M Haffizulla $2,207 ($2,207 in general payments such as food, travel and fees) from 33 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $234.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 10 | $234 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $203 |
| Amgen Inc. AMGN | 13 | $166 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $160 |
| Pfizer Inc. PFE | 6 | $123 |
| Lilly USA, LLC LLY | 11 | $121 |
| Novo Nordisk Inc NVO | 6 | $112 |
| Astellas Pharma US Inc 4503.T | 3 | $97.73 |
| Exact Sciences Corporation EXAS | 3 | $88.34 |
| Corcept Therapeutics CORT | 4 | $84.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.